VYGR
VYGR
NASDAQ · Biotechnology

Voyager Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$2.70
+0.02 (+0.75%)
As of Sep 28, 10:14 PM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 16 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +1,620.0% upside
Low Target $29.94
Average Target $46.44
High Target $64.67
Current Price $2.70
Current
$2.70
Target
$46.44
$29.94 $46.44 avg $64.67
Scenario Analysis
Bear Case
$29.94
1,008.9%
Low target
Base Case
$46.44
+1,620.0%
Avg target
Bull Case
$64.67
+2,295.2%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$5.55
-51.4% from high
52-Week Low
$2.71
+-0.2% from low
Target vs 52W High
$46.44
+736.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -43.4%